PBUS Performance — Invesco MSCI USA ETF
Data updated: 2026-07-30
PBUS returned +11.02% year to date and +29.23% over one year to May 2026. Annualised returns are +23.66% over 3 years and +13.68% over 5 years. The fund beat its US Large Blend category average: $100 invested three years ago grew to $189, against $165 for the category, and to $129 over one year, against $122. Volatility over the past three years was 13.50% a year. In the 12 months to May 2026 the fund took in a net $2.1B, and assets reached $11.45B.
PBUS Growth of $100
What $100 invested in Invesco MSCI USA ETF grew to, compounded from monthly returns reported on SEC Form N-PORT, against the US Large Blend category average over the same months.
| Period | PBUS | Category average |
|---|---|---|
| 1 year (Jun 2025 – May 2026) | $129 | $122 |
| 3 years (Jun 2023 – May 2026) | $189 | $165 |
| 5 years (Jun 2021 – May 2026) | $190 | $164 |
| Since data start (Sep 2019 – May 2026) | $286 | $229 |
PBUS Trailing Returns
Total returns to May 2026, from SEC N-PORT.
| Period | Total return |
|---|---|
| YTD | +11.02% |
| 1 year | +29.23% |
| 3 years (annualised) | +23.66% |
| 5 years (annualised) | +13.68% |
PBUS Annual Returns
Calendar-year total returns of Invesco MSCI USA ETF, compounded from monthly SEC N-PORT returns. Partial years show the months covered.
| Year | Total return |
|---|---|
| 2026 (Jan–May) | +11.02% |
| 2025 | +17.68% |
| 2024 | +25.02% |
| 2023 | +27.06% |
| 2022 | −19.46% |
| 2021 | +26.89% |
| 2020 | +21.32% |
| 2019 (Sep–Dec) | +11.04% |
PBUS Monthly Returns
Monthly total returns as reported on SEC Form N-PORT.
| Year | Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026 | +1.3% | −0.9% | −4.9% | +10.5% | +5.3% | — | — | — | — | — | — | — |
| 2025 | +3.0% | −1.6% | −5.9% | −0.5% | +6.4% | +5.1% | +2.3% | +2.0% | +3.7% | +2.4% | 0.0% | 0.0% |
| 2024 | +1.6% | +5.4% | +3.2% | −4.1% | +4.8% | +3.6% | +1.3% | +2.4% | +2.1% | −0.7% | +6.2% | −2.5% |
| 2023 | +6.6% | −2.4% | +3.5% | +1.3% | +0.6% | +6.7% | +3.4% | −1.7% | −4.7% | −2.3% | +9.4% | +4.7% |
| 2022 | −5.7% | −2.9% | +3.5% | −9.1% | −0.2% | −8.3% | +9.3% | −3.9% | −9.3% | +7.9% | +5.5% | −5.9% |
| 2021 | −0.9% | +2.6% | +3.7% | +5.4% | +0.5% | +2.8% | +2.4% | +2.9% | −4.7% | +7.0% | −1.0% | +3.9% |
| 2020 | +0.2% | −8.1% | −12.6% | +13.1% | +5.2% | +2.3% | +5.9% | +7.5% | −3.7% | −2.6% | +11.5% | +4.1% |
| 2019 | — | — | — | — | — | — | — | — | +1.8% | +2.2% | +3.8% | +2.9% |
PBUS Risk
Risk measures from monthly returns over Jun 2023 – May 2026.
- 3-year volatility (annualised): 13.50%
- 3-year Sharpe ratio: 1.42 (vs 4.5% risk-free rate)
- Best month: +10.50% (Apr 2026)
- Worst month: −5.86% (Mar 2025)
PBUS Fund Flows
Monthly money in and out of Invesco MSCI USA ETF, from SEC Form N-PORT.
- 12-month net flow: $2.1B
- 12-month gross sales (incl. reinvestments): $5.3B
- Sales ÷ redemptions: 1.67×
| Month | Sales | Redemptions | Net flow |
|---|---|---|---|
| May 2026 | $183.7M | $147.6M | $36.1M |
| Apr 2026 | $182.8M | $37.7M | $145.1M |
| Mar 2026 | $210.8M | $198.1M | $12.8M |
| Feb 2026 | $201.9M | $185.1M | $16.7M |
| Jan 2026 | $407.0M | $797.9M | −$390.9M |
| Dec 2025 | $692.5M | $95.0M | $597.5M |
| Nov 2025 | $483.3M | $0 | $483.3M |
| Oct 2025 | $773.8M | $142.8M | $630.9M |
| Sep 2025 | $378.8M | $492.2M | −$113.4M |
| Aug 2025 | $437.5M | $0 | $437.5M |
| Jul 2025 | $1.0B | $999.1M | $6.0M |
| Jun 2025 | $348.7M | $85.4M | $263.4M |
PBUS Assets Under Management
Net assets of Invesco MSCI USA ETF by report date, from SEC N-PORT filings.
| Report date | Net assets |
|---|---|
| 2026-05-31 | $11.45B |
| 2026-02-28 | $10.20B |
| 2025-11-30 | $9.96B |
| 2025-08-31 | $8.45B |
| 2025-05-31 | $7.05B |
| 2025-02-28 | $6.05B |
| 2024-11-30 | $6.08B |
| 2024-08-31 | $5.19B |
| 2024-05-31 | $4.60B |
| 2024-02-29 | $4.51B |
| 2023-11-30 | $3.62B |
| 2023-08-31 | $3.04B |
For information only. Not investment advice: figures are as reported in SEC filings and may contain errors or be out of date. Past performance does not guarantee future results.